People in the News: Kevin Krenitsky, Udit Batra, and more | GenomeWeb

Kevin Krenitsky, Timothy Dec

OpGen announced two new appointments to the firm, including the appointment of Kevin Krenitsky as president. He takes over the role from Evan Jones, who will remain CEO and chairman of OpGen, according to a document filed with the US Securities and Exchange Commission. Krenitsky joins the company, which filed for an initial public offering last month, from Foundation Medicine, where he was chief commercial officer and senior vice president of international strategy. Before that, he was president of Enzo Clinical Labs. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.